136 / 1084
Neoscope Study – Cross Trial Comparison
OE05 (n= 897)
CROSS (n=368)
NEOSCOPE (n=85)
CF
ECX
CarPacRT
CarPacRT
OxCapRT
Grade 3/4 toxicity (any)
30%
47%
Haem 7%
Other 13%
52.4%
42.1%
Surgical complications Resp:27%
Cardiac: 11%
Chylothx:3%
Anas Leak:11%
Resp: 34%
Cardiac: 12%
Chylothx:4%
Anas Leak:10%
Resp: 46%
Cardiac: 21%
Chylothx:10%
Anas Leak:22%
Resp: 36.6%
Cardiac: 9.8%
Chylothx:4.9%
Anas Leak:7.3%
Resp: 38.9%
Cardiac: 25%
Chylothx:2.8%
Anas Leak:0%
© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick
Mukherjee S et al.
ASCO-GI
2016
Post op Mortality
30 day:2%
90 day:4%
30 day:2%
90 day:5%
30 day:4% (4% in S)
>30 day:2% (3% in S)
30 day: 2.4%
90 day:
30 day: 2.8%
90 day:
TRG 1
3%
11%
29% (ACA23%; SC:49%)
27.9%
11.9%
2
3%
6%
32%
37.2%
31%
R0
60%
67% (p=0.059)
92% (69% in S)
80.5%
72.2%